Pharmacotherapeutic group
Antiviral and immunomodulatory agent.
ATH CODE
J05AX
Pharmacological Properties
Pharmacodynamics
Panavir® is a purified extract of the shoots of the plant Solanum tuberosum; The main active ingredient is a hexose glycoside consisting of glucose, rhamnose, arabinose, mannose, xylose, galactose, uronic acids.
Panavir® is an antiviral and immunomodulatory agent. It increases nonspecific resistance to various infections and promotes induction of interferon alpha and gamma by blood leukocytes.
In therapeutic doses the preparation is well tolerated.
Tests showed the absence of mutagenic, teratogenic, carcinogenic, allergic and embryotoxic action. In preclinical studies on laboratory animals no adverse effects on reproductive function and fetal development were found.
It possesses anti-inflammatory properties in the model of experimental exudative edema.
Pharmacokinetics
Pharmacokinetics of the drug has not been studied due to its chemical nature and low active doses.
Indications
Herpesvirus infections of various localizations (including recurrent genital herpes, herpes zoster and ophthalmic herpes).
Secondary immunodeficiency states due to infectious diseases.
Cytomegalovirus infection, including in patients with recurrent miscarriage. It is used in women with chronic viral infection and interferon deficiency in preparation for pregnancy.
Human papillomavirus infection (anogenital warts) as part of complex therapy.
Tick-borne encephalitis to reduce the viral load and relieve neurological symptoms (anisoreflexia, decreased reflexes, pain at exit points of cranial nerves, nystagmus) as part of complex therapy.
ARVI and influenza as part of complex therapy.
Pharmacological effect
PHARMACOTHERAPEUTIC GROUP
Antiviral and immunomodulatory agent.
ATX CODE
J05AX
PHARMACOLOGICAL PROPERTIES
Pharmacodynamics
Panavir® – purified extract of shoots of the Solanum tuberosum plant; the main active ingredient is a hexose glycoside consisting of glucose, rhamnose, arabinose, mannose, xylose, galactose, uronic acids.
The drug Panavir® is an antiviral and immunomodulatory agent. Increases the body’s nonspecific resistance to various infections and promotes the induction of alpha and gamma interferons by blood leukocytes.
The drug is well tolerated in therapeutic doses.
Tests have shown the absence of mutagenic, teratogenic, carcinogenic, allergenic and embryotoxic effects. In preclinical studies on laboratory animals, no negative effects on reproductive function and fetal development were established.
It has anti-inflammatory properties in the model of experimental exudative edema.
Pharmacokinetics
The pharmacokinetics of the drug has not been studied due to its chemical nature and small effective doses.
Special instructions
INFLUENCE ON THE ABILITY TO DRIVE VEHICLES AND MECHANISMS
There is no data on the possibility of a negative effect of the drug on the ability to drive vehicles and carry out potentially hazardous activities that require special attention and speed of psychomotor reactions.
Active ingredient
Panavir
Composition
• Active substance – Panavir® (potato shoots sum of polysaccharides) – 200 mcg
• Excipients: confectionery fat or solid fat – 1.0198 g, paraffin – 0.0900 g, T-2 emulsifier – 0.0900 g.
• Suppository weight – 1.2 g.
Pregnancy
If it is necessary to use the drug during lactation, breastfeeding should be stopped while taking the drug.
Contraindications
• Hypersensitivity
• Pregnancy
• Lactation period
• Children’s age
Side Effects
The drug is well tolerated, possible complications may be associated with individual intolerance and hypersensitivity to the components of the drug.
However, if any unwanted side effects occur, you should stop administering the drug and consult your doctor.
If you notice any other side effects not listed in the instructions, tell your doctor.
Interaction
Not registered.
Overdose
No cases of overdose have been reported. The results of preclinical studies indicate low toxicity of the drug.
Storage conditions
In a dry place, protected from light, at a temperature of 2 to 8 ° C.
Shelf life
3 years
Do not use after the expiration date stated on the package
Manufacturer
Altfarm, Russia
Shelf life | 3 years Do not use after the expiration date on the package |
---|---|
Conditions of storage | In a dry, light-protected place at a temperature of 2 to 8 ° C. |
Manufacturer | Altfarm, Russia |
Medication form | rectal suppositories |
Brand | Altfarm |
Other forms…
Related products
Buy Panavir, rectal 200 mcg 5 pcs with delivery to USA, UK, Europe and over 120 other countries.